Cite
Fadel F, Bazraa HM, Abdelrahman SM, et al. Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients. Open Access Maced J Med Sci. 2017;5(2):222-227doi: 10.3889/oamjms.2017.032.
Fadel, F., Bazraa, H. M., Abdelrahman, S. M., Shouman, M. G., Sayed, M. K., Salah, D. M., Wahby, A. A., & Elgebaly, H. F. (2017). Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients. Open access Macedonian journal of medical sciences, 5(2), 222-227. https://doi.org/10.3889/oamjms.2017.032
Fadel, Fatina, et al. "Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients." Open access Macedonian journal of medical sciences vol. 5,2 (2017): 222-227. doi: https://doi.org/10.3889/oamjms.2017.032
Fadel F, Bazraa HM, Abdelrahman SM, Shouman MG, Sayed MK, Salah DM, Wahby AA, Elgebaly HF. Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients. Open Access Maced J Med Sci. 2017 Apr 13;5(2):222-227. doi: 10.3889/oamjms.2017.032. eCollection 2017 Apr 15. PMID: 28507632; PMCID: PMC5420778.
Copy
Download .nbib